関連する実験動画

Updated: Sep 9, 2025

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

フィトスフィンゴシンは,フリー脂肪酸受容体を標的にすることで,慢性閉塞性肺疾患における煙草による支支支柱上皮細胞衰老を軽減する

Yuan Zhan^1,2, Zhesong Deng¹, Ruonan Yang¹

¹Department of Respiratory and Critical Care Medicine National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei China.

|September 2, 2025

まとめ

フィトスフィンゴシン (PHS) は慢性閉塞性肺疾患 (COPD) の治療の可能性を示しています. PHSは,FFAR4受容体経路を通じて細胞老化を減少させることで,実験的なCOPDにおける肺機能を改善します.

科学分野:

肺医学
細胞生物学
薬理学について

背景:

慢性阻害性肺疾患 (COPD) は進行する呼吸器疾患で,治療の選択肢は限られている.
フィトスフィンゴシン (PHS) は以前,肺機能と正の相関関係を持つCOPDにおける主要な代謝物として特定されました.

研究の目的:

実験的なCOPDに対するPHSの治療効果を調査する.
COPD モデルにおける PHS 作用の基礎となる分子メカニズムを解明する.

主な方法:

タバコの煙 (CS) に誘発されたマウスと細胞モデルがCOPDを模倣するために使用されました.
PHS,FFAR4過剰発現 (AAV),FFAR4アゴニスト (TUG891) を使用した.
細胞老化と老化に関連した分泌現象マーカーを分析した.

主要な成果:

PHS治療は,CS誘発の肺機能障害,肺気腫,呼吸道炎症を改善しました.
PHSは,細胞老化と老化に関連した分泌現象を支柱上皮質で減少させた.
PHSは,自由脂肪酸受容体4 (FFAR4) の発現を調節し,STUB1とP53のユビキチネーションを調節し,老化を緩和した.

結論:

PHSは,FFAR4媒介経路をターゲットにすることで,実験的なCOPDにおける有益な効果を示しています.
PHSはタバコの煙によって引き起こされる支氣管上皮細胞の老化から保護します.
PHSはCOPDの治療に有望な治療候補である.

キーワード:

細胞の老化慢性閉塞性肺疾患タバコの煙自由脂肪酸受容体 4 フィトスフィンゴシン

さらに関連する動画

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

関連する概念動画

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Breathing

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...